Article
How evolution of mutations conferring drug resistance affects viral dynamics and clinical outcomes of cytomegalovirus-infected hematopoietic cell transplant recipients.
Journal of clinical microbiology - 1 Jan 2005
Springer Kathryn L, Chou Sunwen, Li Shaobing, Giller Roger H, Quinones Ralph, Shira James E, Weinberg Adriana
Abstract excerpt
Infection with cytomegalovirus (CMV) remains a significant cause of morbidity and mortality among hematopoietic cell transplant (HCT) recipients. We describe two pediatric HCT recipients who developed persistent and severe drug-resistant CMV infections. CMV resistance to foscarnet and ganciclovir was detected after only 6 and 11 weeks of therapy, respectively. Viral pol mutations associated with drug resistance...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
